MannKind

US · MNKD #3124 by market cap Listed 2016

3.45 -0.26 -7.01%

Live - 5344 symbols - heartbeat 309s ago · 2026-10-08 07:12

Pre-market 3.49 +1.16%

After-hours 3.46 +0.29%

Overnight 3.49 +1.16%

Market cap: 1.11B
P/E (TTM): -24.64
P/B: -16.51
EPS: 0.02
Div yield: 0.00%
52W pos: 29%

Reader sentiment Are you bullish or bearish on MNKD?

Anonymous reader poll. Unscientific, not investment advice.

About MannKind

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Founded: 1991
CEO: Mr. Michael E. Castagna, Pharm.D.
Employees: 592
Headquarters: Danbury, Connecticut, United States of America
Fiscal year end: 12-31
Website: mannkindcorp.com

Company profile

Exchange: US
Symbol: MNKD
Market-cap rank: #3124
Listing date: 2016-05-10
Market cap: 1.11B
Float cap: 1.03B
Shares out: 321.54M
Float shares: 297.60M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:12:30 · For reference only, not investment advice and not tailored to your situation.